1 active not recruiting. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Active not recruiting 1 |
Follow Louis Messina: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Effects of ATLAS Therapy on Nitric Oxide Bioavailability in Patients With Intermittent Claudication Tetrahydrobiopterin 10 mg/kg, Tetrahydrobiopterin 20 mg/kg, L-Ascorbate - Claudication, Intermittent, Peripheral Artery Disease | Phase 1 | Active not recruiting | Louis Messina | 10 | 2021-06-15 | 2026-04-15 |
Intermittent Claudication (1) · Peripheral Arterial Disease (1) · Peripheral Vascular Diseases (1)
Arginine (1) · sapropterin (1)
United States (1)